INVESTIGATION OF FACTORS ASSOCIATED WITH THE SEVERITY OF HEPATIC ENCEPHALOPATHY IN CIRRHOTIC PATIENTS AT CAN THO CENTRAL GENERAL HOSPITAL

Phương Tô Thị Diễm, Liêm Nguyễn Thanh , Nho Lê Văn

Main Article Content

Abstract

Background: Hepatic encephalopathy (HE) is a common complication in cirrhotic patients, signaling a poor prognosis and increasing mortality rates. Identifying factors associated with HE severity is essential for early prevention and management, thereby improving patient outcomes. Objectives: To investigate several factors associated with the severity of hepatic encephalopathy in patients with liver cirrhosis. Materials and methods: A cross-sectional descriptive study with analytical components was conducted on 82 cirrhotic patients treated at Can Tho Central General Hospital from January 2024 to January 2025. Results: Regarding general characteristics, the male-to-female ratio was approximately 1.65, with a mean age of 61.91 ± 14.08 years; the majority (56.1%) were over 60 years old. The most common etiologies of cirrhosis were hepatitis B virus infection (32.9%) and alcohol-related liver disease (22.0%). Most patients were classified as Child-Pugh C (61.0%). Grade II HE accounted for 50.0%, a proportion equivalent to the combined total of grade III and IV HE, with grade III HE making up 36.6%. Assessment of factors related to HE severity showed that gastrointestinal bleeding was significantly associated with an increased likelihood of grade III–IV HE, with an odds ratio (OR) of 2.8 (95% CI: 1.1–7.3), p = 0.034. Furthermore, the neutrophil-to-lymphocyte ratio (NLR) was significantly higher in patients with grade III and IV HE compared to those with grade II HE (p < 0.05). No association was found between serum ammonia levels and HE severity. Conclusion: Gastrointestinal bleeding and elevated NLR are associated with increased severity of hepatic encephalopathy. 

Article Details

References

1. Elwir S, Rahimi RS (2017), "Hepatic Encephalopathy: An Update on the Pathophysiology and Therapeutic Options", J Clin Transl Hepatol, 5(2), pp. 142-151.
2. Vilstrup H, Amodio P, Bajaj J, et al. (2014), "Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver", Hepatology, 60(2), pp. 715-35.
3. Tapper EB, Henderson JB, Parikh ND, et al. (2019), "Incidence of and Risk Factors for Hepatic Encephalopathy in a Population-Based Cohort of Americans With Cirrhosis", Hepatol Commun, 3(11), pp. 1510-1519.
4. European Association for the Study of the Liver (2022), "EASL Clinical Practice Guidelines on the management of hepatic encephalopathy", J Hepatol, 77(3), pp. 807-824.
5. Elias TP, Shewaye AB, Fisseha H, et al. (2025), "Predictors of in-hospital mortality among cirrhotic patients in Ethiopia: A multicenter retrospective study", PLoS One, 20(4), pp. e0322532.
6. Bleibel W, Al-Osaimi AM (2012), "Hepatic encephalopathy", Saudi J Gastroenterol, 18(5), pp. 301-9.
7. Demirciler E, Danis N, Ergun P, et al. (2023), "Psychometric tests, critical flicker frequency, and inflammatory indicators in covert hepatic encephalopathy diagnosis", Hepatol Forum, 4(1), pp. 19-24.
8. Sharma P, Sharma BC (2010), "Predictors of minimal hepatic encephalopathy in patients with cirrhosis", Saudi J Gastroenterol, 16(3), pp. 181-7.